Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6075457 | Journal of Investigative Dermatology | 2015 | 4 Pages |
Abstract
Toxic epidermal necrolysis (TEN) is a rare but potentially fatal drug hypersensitivity reaction. Although a number of pathophysiological hints have been identified over the past decade, details of the effector mechanisms within the skin remain obscure. A novel study by Kim et al. now sheds light on its pathophysiology. The investigators demonstrate convincingly that receptor-interacting kinase 3 (RIPK3) levels are upregulated substantially in the lesional skin of patients with TEN and that this is followed by the generation of reactive oxygen species, activation of mixed lineage kinase-like protein, and subsequent necroptotic cell death of keratinocytes. These data suggest that therapies that interfere with RIPK3 activation and necroptosis induction could benefit patients with TEN.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Diana Panayotova-Dimitrova, Maria Feoktistova, Martin Leverkus,